F293-0971 Screening compound: 5-(4-methoxybenzenesulfonamido)-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid

F293-0971 Screening compound: 5-(4-methoxybenzenesulfonamido)-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid
F293-0971 Screening compound: 5-(4-methoxybenzenesulfonamido)-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound F293-0971
5-(4-methoxybenzenesulfonamido)-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F293-0971

Molecular Formula

C23H30N4O5S (C23 H30 N4 O5 S)

Compound Name

5-(4-methoxybenzenesulfonamido)-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid

IUPAC name

5-(4-methoxybenzenesulfonamido)-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid

SMILES

COc(cc1)ccc1S(Nc(cc1C(O)=O)cnc1N1CC(CN2CCCC2)CCC1)(=O)=O

InChI

InChI=1S/C23H30N4O5S/c1-32-19-6-8-20(9-7-19)33(30,31)25-18-13-21(23(28)29)22(24-14-18)27-12-4-5-17(16-27)15-26-10-2-3-11-26/h6-9,13-14,17,25H,2-5,10-12,15-16H2,1H3,(H,28,29)/t17-/m1/s1

InChI Key

WGXUOOPSBMAXNF-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD27113011

Chemical and Physical Properties

Saltdata

CF3COOH

Molecular Weight

474.58

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.305

Distribution Coefficient, logD

3.305

Water Solubility, LogSw

-3.67

Polar Surface Area

93.395

Acid Dissociation Constant (pKa)

5.80

Base Dissociation Constant (pKb)

9.04

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.80

F293-0971 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Eccentric PPI Library (11937 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F293-0971 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F293-0971?
Check Price and Availability of F293-0971, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F293-0971 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F293-0971
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F293-0971
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F293-0971 available by request